Clinical Trial Update: A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents [Phase 2]

View source ↗

Summary

Phase 2 study evaluating antiviral activity of darunavir plus ritonavir in HIV-1 infected adolescents; results of the completed trial were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2011-12-28